Precision Therapeutics Closes on $20 Million in Venture Funding
February 21, 2006
Precision Therapeutics has raised $20 million in venture capital funds marking the region's first big funding round of 2006, according to an article in the Pittsburgh Business Times. The final amount was more than 40% above what the company originally sought when it began raising funds last summer. CEO Sean McDonald expects this to be its last venture round as they will use the money to market their tissue-based support tool that helps clinicians select the most effective chemotherapy regiment for individual patients, a move which should bring the company to profitability.
« Aethon's Zini Shares Lesson Learned | | Imago Microscope Leads to Northwestern Research Advance »
